Skip to main content
OpenTrials
Completed

NCT Number: NCT00800774

Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old

The purpose of this study is to determine the safety, efficacy, predictability, and stability of laser in situ keratomileusis (LASIK) to correct high anisometropia in patients 8 to 15 years old in whom conventional treatments have failed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anisometropia Eye Diseases Refractive Errors

Age range

8 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

IOG

Goiânia, Goiás, Brazil

About this study

Nine eyes of nine patients (3 male and 6 female) with high anisometropia (>3.50 D), were included in this study. Minimum follow-up was 10 years. All patients were treated with the Chiron Technolas 217 excimer laser.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • High anisometropia (>3.50 D)
  • Patients 8 to 15 years old
  • Conventional treatments have failed

Exclusion criteria

  • Diabetes
  • Autoimmune diseases
  • Topographic abnormalities

Treatment and study plan

LASIK

Procedure

Nine eyes of nine patients (3 male and 6 female) with high anisometropia (>3.50 D), were included in this study. Minimum follow-up was 10 years. All patients were treated with the Chiron Technolas 217 excimer laser.

Sponsors and collaborators

Lead sponsor

Instituto de Olhos de Goiania

Other

Registry information

Important dates

Study start
1998
Primary completion
2008
Study completion
2008
First posted
Dec 2, 2008
Registry last updated
Nov 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.